# Diltiazem

Drug · id `cardio:diltiazem` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Cardizem; Diltiazem hydrochloride

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

Diltiazem is a calcium channel blocker taken by mouth. The US label read, for Cardizem, lists one use: the management of chronic stable angina and angina due to coronary artery spasm. Cardizem CD and Cardizem LA are separate extended-release products with their own labels, which were not read.

## Technical summary

RxNorm ingredient 3443; UNII OLH94387TE. The label names the substance as diltiazem hydrochloride, so UNII OLH94387TE is the UNII of the salt form and is a broad match. MeSH descriptor D004110 is Diltiazem. Class: Calcium Channel Blocker (FDA established pharmacologic class, RxClass). The label read is the CARDIZEM (diltiazem hydrochloride) tablets, Bausch Health US LLC label, effective 2025-04-30 in openFDA (application NDA018602). Other diltiazem labels in openFDA, from other sponsors and repackagers, were not read. This page records label indications and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People for whom the US label of diltiazem (Cardizem) lists an indication: chronic stable angina, angina due to coronary artery spasm

Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passages read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of CARDIZEM (diltiazem hydrochloride), in the Bausch Health US LLC version dated 2025-04-30 in openFDA, lists the medicine for the management of chronic stable angina and angina due to coronary artery spasm.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passages read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-09
- Sources:
  1. Supports: openFDA drug label record for CARDIZEM (diltiazem hydrochloride) tablets, Bausch Health US LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id f3e7ecef-f360-4987-a4f5-933214130ab2 (manufacturer Bausch Health US LLC, application NDA018602), returned on 2026-11-09. The label text is dated 2025-04-30 (effective\_time). Other openFDA records of diltiazem labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22f3e7ecef-f360-4987-a4f5-933214130ab2%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 31d00490399711edd34a07a6130c2ebbb66e5d41bbddddf7b5da4f66b78e7d14.
     How it applies: The label sentences that give the indications named in the statement, each quoted in the research quote table.
  2. Background: openFDA drug label record for CARDIZEM (diltiazem hydrochloride) tablets, Bausch Health US LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id f3e7ecef-f360-4987-a4f5-933214130ab2 (manufacturer Bausch Health US LLC, application NDA018602), returned on 2026-11-09. The label text is dated 2025-04-30 (effective\_time). Other openFDA records of diltiazem labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22f3e7ecef-f360-4987-a4f5-933214130ab2%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:17:41Z. Source state: Current. Version fingerprint: 31d00490399711edd34a07a6130c2ebbb66e5d41bbddddf7b5da4f66b78e7d14.
     How it applies: Effective date of the label text read, 20250430.

## Connected pages

- Diltiazem is a calcium channel blocker (FDA established pharmacologic class in RxClass): Calcium channel blockers (`cardio:calcium-channel-blockers`)
- FDA label lists the management of chronic stable angina as an indication: Stable angina (`cardio:stable-angina`) [a claim, not a settled fact; see claim `cardio:claim-fda-diltiazem-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry products
- 6 registry trials

## Provenance

Content hash: a3ca390ad26d314abaedccd7a409bef33efd7cb4dd2743cff527c823d4c39537
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
